GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Days Sales Outstanding

Labiana Health (XMAD:LAB) Days Sales Outstanding : 65.17 (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Days Sales Outstanding?

Labiana Health's average Accounts Receivable for the six months ended in Dec. 2022 was €10.28 Mil. Labiana Health's Revenue for the six months ended in Dec. 2022 was €28.79 Mil. Hence, Labiana Health's Days Sales Outstanding for the six months ended in Dec. 2022 was 65.17.

The historical rank and industry rank for Labiana Health's Days Sales Outstanding or its related term are showing as below:

XMAD:LAB's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 72.035
* Ranked among companies with meaningful Days Sales Outstanding only.

Labiana Health's Days Sales Outstanding increased from Dec. 2021 (0.00) to Dec. 2022 (65.17).


Labiana Health Days Sales Outstanding Historical Data

The historical data trend for Labiana Health's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Days Sales Outstanding Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Days Sales Outstanding
66.07 58.97 52.72

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Days Sales Outstanding - - 61.90 65.17

Competitive Comparison of Labiana Health's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Labiana Health's Days Sales Outstanding falls into.



Labiana Health Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Labiana Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (7.934 + 8.778) / 2 ) / 57.848*365
=8.356 / 57.848*365
=52.72

Labiana Health's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

Days Sales Outstanding (Q: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (11.781 + 8.778) / 2 ) / 28.787*365 / 2
=10.2795 / 28.787*365 / 2
=65.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labiana Health  (XMAD:LAB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Labiana Health Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Labiana Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.